Ascendiant Capital Markets Analysts Begin Coverage on Apricus Biosciences ...
Daily Political
Apricus Biosciences logo Research analysts at Ascendiant Capital Markets assumed coverage on shares of Apricus Biosciences (NASDAQ: APRI) in a report released on Monday. The firm set a “strong-buy” rating and a $6.00 price target on the stock.

and more »


More...